Cencora, Inc. reports news around its role as a global pharmaceutical solutions organization that distributes branded, generic and specialty pharmaceuticals to pharmacies, hospital networks and healthcare providers. Company updates also cover commercialization services for pharmaceutical and medical-device manufacturers, specialty drug logistics through World Courier, animal health distribution through MWI Animal Health and international wholesale activity following the Alliance Healthcare acquisition.
Recurring developments include fiscal operating results, gross profit drivers, LIFO effects, GLP-1 product mix and performance in U.S. Healthcare Solutions. News also covers completed acquisitions such as OneOncology and Retina Consultants of America, senior note financing, shareholder and governance matters, and executive leadership transitions.
AmerisourceBergen Corporation (NYSE: ABC) plans to release its Second Quarter Fiscal 2021 results on May 5, 2021, prior to NYSE trading. The conference call to discuss these results will occur at 8:30 a.m. ET on the same day, featuring CEO Steven H. Collis and CFO James F. Cleary. Interested parties can join via a dial-in number or a live webcast available on the company's investor relations website. Replays will be accessible for one year via the webcast and for seven days via telephone.
AmerisourceBergen is recognized as a leading global healthcare firm with substantial annual revenue.
AmerisourceBergen (NYSE: ABC) has successfully closed a public offering totaling $2.525 billion, comprising $1.525 billion in 0.737% Senior Notes due March 15, 2023, and $1 billion in 2.700% Senior Notes due March 15, 2031. Proceeds will fund the acquisition of Walgreens Boots Alliance's Alliance Healthcare businesses and cover related expenses. The offering was conducted under a shelf registration statement filed with the SEC on November 20, 2018.
AmerisourceBergen Corporation (NYSE: ABC) has priced $1.525 billion in 0.737% Senior Notes due March 15, 2023, and $1 billion in 2.700% Senior Notes due March 15, 2031. The offering, underwritten by J.P. Morgan and others, is set to close on March 30, 2021. Proceeds will finance the acquisition of Walgreens Boots Alliance’s Alliance Healthcare businesses, along with related fees and general corporate purposes. This initiative highlights ABC's strategic growth through targeted acquisitions and financing.
AmerisourceBergen Corporation (NYSE: ABC) reported a 9.7% increase in revenue year-over-year, reaching $52.5 billion for Q1 of fiscal year 2021 ending December 31, 2020. The company's diluted earnings per share (EPS) was reported at $1.81, up from $0.90 a year earlier. Adjusted diluted EPS rose 24% to $2.18. The Company has also updated its outlook for fiscal year 2021, signaling potential growth ahead.
AmerisourceBergen Corporation (NYSE: ABC) has declared a quarterly dividend of $0.44 per common share, set to be paid on March 1, 2021. This dividend will be distributed to stockholders recorded as of the close of business on February 12, 2021. As a leading provider in the pharmaceutical supply chain, AmerisourceBergen generated over $185 billion in annual revenue and ranks #10 on the Fortune 500 list, demonstrating its significant market presence.
AmerisourceBergen Corporation (NYSE: ABC) has updated its fiscal year 2021 guidance, projecting adjusted diluted earnings per share (EPS) between $8.25 and $8.50, an increase from the previous range of $8.20 to $8.45. This revision reflects strong operating income performance and does not account for any contributions from the anticipated Alliance Healthcare acquisition or the newly announced U.S. partnership. The company will further discuss this updated outlook in upcoming investor discussions.
AmerisourceBergen (ABC) will acquire Walgreens Boots Alliance's (WBA) Alliance Healthcare for $6.5 billion, comprising $6.275 billion in cash and 2 million shares. This acquisition enhances AmerisourceBergen's global distribution capabilities and allows WBA to focus on its retail pharmacy expansion. The deal is projected to create annual run-rate synergies of at least $150 million by the fourth year. Additionally, the U.S. distribution agreement is extended to 2029, aiming for greater efficiencies. AmerisourceBergen expects a high-teens percentage accretion to adjusted EPS in the first fiscal year after closing.
AmerisourceBergen (NYSE: ABC) is set to disclose its First Quarter 2021 results on February 4, 2021, before NYSE trading opens. A conference call will follow at 8:30 a.m. ET, featuring Steven H. Collis, CEO, and James F. Cleary, CFO. Interested parties can join the call at (844) 808-6694 or via a webcast on the company’s website. Additionally, AmerisourceBergen will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on January 5, 2021, and the J.P. Morgan Healthcare Conference on January 11, 2021.
AmerisourceBergen Corporation (ABC) reported a 7.9% revenue increase to $49.2 billion for Q4 fiscal 2020, with full fiscal year revenue up 5.7% to $189.9 billion. Despite a GAAP diluted EPS loss of $(23.74) due to a $6.6 billion opioid litigation expense, adjusted diluted EPS rose 17.4% to $1.89. The company emphasized its resilience and growth potential for fiscal 2021, focusing on its pharmaceutical-centric services. A quarterly dividend of $0.44, up 5%, was also declared, payable on November 30, 2020.
AmerisourceBergen Corporation (NYSE: ABC) will release its Fourth Quarter Fiscal 2020 results on November 5, 2020, before the NYSE opens. A conference call is scheduled at 8:00 a.m. ET the same day, featuring CEO Steven H. Collis and CFO James F. Cleary. Investors can join the call by dialing (844) 808-6694 or from outside the U.S. at +1 (412) 317-5282. The event will also be webcast on the company's investor relations website. Replays will be available shortly after the call concludes.